As AI-generated influencers begin to enter the marketing mix, pharma faces both a powerful opportunity and a critical risk.
In a new article published on Med Ad News (Pharma Live), Chief Creative Officer Susan Perlbachs explores what recent consumer backlash to AI influencers reveals about the future of influence in healthcare. The takeaway isn’t that audiences reject AI, but that they reject anything that lacks perspective, purpose, or genuine human value.
As the industry moves closer to an AI influencer reality, one question will define what works—and what doesn’t. Read the full article to explore what pharma must get right before leaning into this next frontier.